hs-CRP for Cardiovascular Risk in Diabetes: Problems in Daily Practice

Journal Title: Turkish Journal of Endocrinology and Metabolism - Year 2006, Vol 10, Issue 2

Abstract

Serum levels of high-sensitivity C-reactive protein (hs-CRP) have been found to be a strong predictor for increased cardiovascular disease risk associated with type 2 diabetes independent of traditional risk factors. However, it is well known that hs- CRP level is influenced by various factors. In this study, we evaluated the nonmetabolic factors affecting hs-CRP levels and their frequency, and we studied whether measuring hs-CRP has a clinical significance as a predictor for prognosis, in patients with type 2 diabetes. Ninety-one consecutive patients (56 female, 35 male, mean (±SD) age: 53.7±10.2 years) with type 2 diabetes mellitus admitted to the Diabetes Outpatient Clinic of Istanbul Goztepe Training and Research Hospital were enrolled in this study. Medical history, physical examination, and laboratory findings of these subjects were evaluated in terms of the factors influencing hs-CRP level. 16.4% of patients had at least one of the non-metabolic factors increasing hs-CRP levels. Frequencies for smoking, hormone replacement therapy, acute infections and chronic infections were 14.2%, 3.2%, 7.6% and 4.3%, respectively. In the present study, at least one of the non-metabolic factors capable of increasing hs-CRP levels was found in one of every six patients with type 2 diabetes, suggesting a limited use of hs-CRP for predicting cardiovascular risk.

Authors and Affiliations

Elif Yorulmaz, Mehmet Uzunlulu, Banu Alpaslan, Aytekin Oğuz

Keywords

Related Articles

Selective Estrogen Receptor Modulators: From Molecular Basis to Clinical Application

Women's Health Initiative Study have challenged the paradigms about the treatment modalities of postmenopausal period. Further alternative therapeutic options, which should be safer than the hormon replacement therapy ar...

The Level of Antithrombin III (AT III) in Turkish Diabetics

A natural anti-coagulant AT III plays a defensive role against intravascular coagulation and regulates blood hemostasis. Diabetes is associated with hypercoagulable state. The level of blood AT III levels in the Turkish...

Homocysteine Levels and Catalase Activities in Type 2 Diabetic Subjects with Vascular Complications

The aim of this study was to determine the association between homocysteine levels and macroangiopathic/microangiopathic complications in type 2 diabetes mellitus (DM), folate and vitamin B 12 levels, antioxidant enzyme...

Primary Pituitary Abscess Mimicking an Adenoma: A Rare Entity

Pituitary abscesses, rare lesions, may be divided into primary and secondary types. A 26-years-old woman presented with decreasing vision, and headache. Magnetic resonance images (MRI) was suggestive of a sellar tumour....

Diabetic Extremity Infections

Extremity infections, especially the lower extremity infections, are the most common complication and cause of admittance to hospital in people with diabetes mellitus. The rate of lower March amputation is 40 times highe...

Download PDF file
  • EP ID EP83122
  • DOI -
  • Views 161
  • Downloads 0

How To Cite

Elif Yorulmaz, Mehmet Uzunlulu, Banu Alpaslan, Aytekin Oğuz (2006). hs-CRP for Cardiovascular Risk in Diabetes: Problems in Daily Practice. Turkish Journal of Endocrinology and Metabolism, 10(2), 35-38. https://europub.co.uk/articles/-A-83122